LATTS Act of 2017
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Apr 6, 2017)
Label and Transport Tissues Safely Act of 2017 or the LATTS Act of 2017
This bill prohibits the sale of human tissue for research or education unless the seller has a non-transplant tissue bank license, each package of tissue is labeled with specified information, and each package is wrapped in the prescribed manner.
The Department of Health and Human Services (HHS) shall establish a process for the approval, suspension, and revocation of non-transplant tissue bank licenses.
False labeling of packages of human tissue is prohibited.
HHS or any accrediting body authorized by HHS is allowed to enter and inspect any facility that is subject to a non-transplant tissue bank license.
HHS shall recall any human tissue specimen that is an imminent or substantial hazard to public health.
The bill makes it unlawful to knowingly sell or otherwise transfer any human tissue specimen if the transfer affects interstate commerce.
What just happenedApr 7, 2017
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseApr 6, 2017
- Apr 7, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Apr 6, 2017IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Apr 6, 2017IntroReferralIntro-H
Introduced in House
- Apr 6, 2017IntroReferral1000
Introduced in House